GlassScriptPhysician profile
Cammy E Beglin
NPI 1649351560
$2,142.99
in general payments reported to CMS, 2019-2025
24 companies · $457 in 2025
The $457 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $150 · 2021: $178 · 2022: $86.85 · 2023: $462 · 2024: $638 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $511.16 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $354.02 | 2022-2025 | Acessa Provu System, Myosure Tissue Removal Device, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $169.27 | 2019-2025 | Slynd |
| Abbvie INC. | $146.41 | 2019-2023 | Lo Loestrin Fe |
| Biogen, INC. | $138.79 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $103.11 | 2022-2025 | |
| Organon LLC | $92.83 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $84.24 | 2019-2023 | Gardasil 9 |
| Intuitive Surgical, INC. | $79.45 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $65.50 | 2023 | |
| Sumitomo Pharma America, INC. | $63.64 | 2024-2025 | Myfembree |
| Daiichi Sankyo INC. | $48.61 | 2019-2021 | |
| Exact Sciences Corporation | $34.18 | 2023 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $31.42 | 2020 | |
| Smith+Nephew, INC. | $30.07 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $29.21 | 2020 | |
| Baxter Healthcare | $28.20 | 2025 | Perclot |
| Coopersurgical, INC. | $25.60 | 2025 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $22.07 | 2020 | |
| Agile Therapeutics, INC. | $21.87 | 2021 | |
| Millicent US INC | $20.84 | 2025 | Femlyv |
| Dysis Medical, INC. | $16.33 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.20 | 2020 | |
| Therapeuticsmd, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cammy Beglin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.